Results 231 to 240 of about 48,247 (244)

Direct-acting antivirals for paediatric HCV: we got there

Nature Reviews Gastroenterology & Hepatology, 2017
In a new report, adolescents with genotype 2 or 3 HCV infection who were given sofosbuvir and ribavirin showed a near 100% sustained virologic response. This study is the beginning of a new wave of treatments for paediatric HCV infection, forming part of a global strategy to eradicate viral hepatitis.
openaire   +2 more sources

Direct acting antiviral‐induced/exacerbated psoriasis: Addendum!

Dermatologic Therapy, 2019
Ayman Abdelmaksoud, Michelangelo Vestita
openaire   +2 more sources

Direct-acting antiviral treatment for hepatitis C

The Lancet, 2019
Jacinta A, Holmes, Stephanie M, Rutledge, Raymond T, Chung   +2 more
openaire   +2 more sources

Direct acting antivirals

Reactions Weekly, 2019
openaire   +1 more source

Direct-acting antiviral agents

Reactions Weekly, 2019
openaire   +1 more source

Direct‐acting antivirals and recurrence of hepatocellular carcinoma

Liver Transplantation, 2017
Jorge A, Marrero, Amit G, Singal
openaire   +2 more sources

Direct-acting antiviral therapy in sub-Saharan Africa

The Lancet Gastroenterology & Hepatology, 2019
C Wendy, Spearman, Mark W, Sonderup
openaire   +2 more sources

Tacrolimus/unspecified direct acting antivirals interaction

Reactions Weekly, 2018
openaire   +1 more source

Warfarin: interaction with direct-acting antivirals

Reactions Weekly, 2016
openaire   +1 more source

HCV Direct-acting Antivirals: Real World Data

2016
Hosted by The Hong Kong Association for the Study of Liver Diseases & The Hong Kong Society for Infectious ...
openaire   +1 more source